We have advised bMEDcare, a specialist in dermatological care and nutritional supplements, on its sale to Healthcare Brands Group (HBG), a portfolio company of Arcola Private Equity. This transaction marks an important milestone for bMEDcare, as it joins a rapidly growing platform of leading healthcare and personal care brands.
With a strong presence in the Benelux region, bMEDcare is dedicated to promoting ‘positive health’ through close collaboration with medical professionals, R&D labs, customers, and retailers. The company owns and markets two highly regarded brands: Dermolin and Essential Organics, each catering to a growing demand for high-quality, dermatologically tested skincare and premium, natural dietary supplements.
Dermolin is a trusted dermacare brand offering a broad range of hypoallergenic, fragrance-free, and soap-free cleansing and skincare products. Originally developed in 1992 by dermatologists and hospitals, Dermolin has grown to become the only drugstore brand recommended by dermatologists in the Netherlands. Its products are designed specifically to prevent skin irritation and sensitivity, serving a loyal customer base seeking gentle yet effective skincare solutions.
Essential Organics is a pioneering dietary supplement brand, first launched in 1976, focusing on pure, plant-based nutrition. The brand’s innovative Pure Line capsules, introduced in 2017, have driven significant growth, offering 100% plant-based, additive-free supplements made with premium natural ingredients. Additionally, bMEDcare supplies medical institutions with critical vitamins through its Essential Orgadek sub-brand, ensuring healthcare professionals have access to high-quality nutritional solutions for patient care.
Operating under a lean, asset-light B2B2C business model, bMEDcare focuses purely on marketing, sales, and media, while leveraging strategic partnerships with trusted external manufacturers and suppliers. All of its products are designed and produced in the Netherlands, reinforcing its commitment to premium quality and local expertise.
Acquired in 2017 by Mr. Boudewijn Meyer and Mr. Edwin Driesenaar, bMEDcare has since achieved impressive market growth and profitability, strengthened its retail partnerships and expanded its consumer reach. By joining Healthcare Brands Group, bMEDcare is well-positioned to accelerate its growth trajectory, benefiting from HBG’s enhanced digital marketing capabilities and operational synergies. The acquisition will provide bMEDcare with the resources needed to further expand its brand presence internationally.
With HBG’s infrastructure and economies of scale, bMEDcare will unlock cost efficiencies, supply chain optimisation, and portfolio expansion opportunities, ensuring it remains at the forefront of evolving consumer needs. Backed by HBG and Arcola Private Equity, and with a strong track record of revenue growth, high margins, and increasing EBITDA, bMEDcare is well-positioned for its next phase of expansion.
We acted as the exclusive financial adviser to bMEDcare, working closely with the company’s leadership team to secure the ideal strategic partner. Through a tailored transaction process, we successfully guided the transaction to completion, ensuring a seamless transition and a strong outcome for all stakeholders involved. This deal highlights our expertise in advising high-growth healthcare and consumer brands, reinforcing our commitment to help entrepreneurs and businesses achieve their strategic and financial ambitions.
